Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling
Oncology Research · 2024
DOI: 10.32604/or.2024.045025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2024. Verfasst von Yue Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutics, College of Life Sciences and Medicine, Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Zhe…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, ErbB Receptors, Lung Neoplasms, Neoplasm Invasiveness. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biopharmaceutics, College of Life Sciences and Medicine, Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
- Department of Thoracic Surgery, Zhejiang Provincial People's Hospital, Hangzhou, 310014, China.
Zitieren
APA
Zhang, Y., Yang, W., Han, X., Qiao, Y., Wang, H., Chen, T., Li, T., & Ou, W. B. (2024). Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling. Oncology Research. https://doi.org/10.32604/or.2024.045025
Vancouver
Zhang Y, Yang W, Han X, Qiao Y, Wang H, Chen T, et al. Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling. Oncology Research. 2024. doi:10.32604/or.2024.045025
BibTeX
@article{Zhang2024,
author = {Zhang, Yue and Yang, Wenyu and Han, Xiaowang and Qiao, Yue and Wang, Haitao and Chen, Ting and Li, Tianying and Ou, Wen-Bin},
title = {Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling},
journal = {Oncology Research},
year = {2024},
doi = {10.32604/or.2024.045025}
}
EUVIMED